Owners, management and financials
CVR: 28486871
Secondary names: V-Biotek ApS
Previous names: VIND INVEST ApS, V-BIOTEK ApS
DKK -1,214,608
Gross profit
Net result: DKK -3,201,378
V-BIOTEK HOLDING ApS (5-9,99%), Redwood Foundation ApS (5-9,99%)
1 more
CVR · view owners
Christian Hother Sørensen
Board: Nicolai Fink Gundersen (chair) and 3 members
CVR · view management
Active
Founded 14 February 2005
CVR · view overview
0 employees
CVR · 2018
Owner registered: V-BIOTEK HOLDING ApS
CVR · 20/12/2024
View the full event history
Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.
Selskabets formål er at drive virksomhed inden for medicinalbranchen, branchen for naturlægemidler og hygiejneprodukter og enhver hermed beslægtet branche efter ledelsens skøn.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -3.2 mio. | 2 mio. | 594 t. | 2 | |
| 202401/01/2024 – 31/12/2024 | - | -1.5 mio. | 3.3 mio. | 795 t. | 2 | |
| 202301/01/2023 – 31/12/2023 | - | -2.1 mio. | 1.5 mio. | -1.7 mio. | 2 | |
| 202201/01/2022 – 31/12/2022 | - | -3.5 mio. | 1.3 mio. | -3.6 mio. | 2 | |
| 202101/01/2021 – 31/12/2021 | - | -4.5 mio. | 2.9 mio. | -2.5 mio. | 2 | |
| 202001/01/2020 – 31/12/2020 | - | -3.2 mio. | 4.1 mio. | -976 t. | 2 | |
| 201801/07/2017 – 30/06/2018 | - | -88 t. | 2.6 mio. | 2.4 mio. | - | |
| 201701/07/2016 – 30/06/2017 | - | -2.2 mio. | 3.1 mio. | 121 t. | 1 | |
| 201601/07/2015 – 30/06/2016 | 200 t. | -1.8 mio. | 4 mio. | -3.2 mio. | - | |
| 201501/07/2014 – 30/06/2015 | 1.2 mio. | -1.1 mio. | 3.8 mio. | -1.3 mio. | - | |
| 201401/07/2013 – 30/06/2014 | - | -26 t. | 705 t. | -178 t. | - | |
| 201301/07/2012 – 30/06/2013 | - | -152 t. | 692 t. | -152 t. | - |
Compared to 1.039 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Fenucure Medical ApS is 28486871.
Fenucure Medical ApS is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS.
The management of Fenucure Medical ApS consists of Christian Hother Sørensen.
The board of Fenucure Medical ApS consists of Nicolai Fink Gundersen, Alex Gundersen and Mogens Viktor Madsen, with Nicolai Fink Gundersen as chair.
In 2025, Fenucure Medical ApS reported a gross profit of DKK -1,214,608.
Fenucure Medical ApS had 0 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 81448132, new email: [email protected], new website: fenucure.com (June 18, 2026).
Fenucure Medical ApS has published its annual report for 2025. Gross profit came to DKK -1,214,608, and the net result was DKK -3,201,378.
As of May 13, 2026, Jørgen Schönherr has left the board of directors of Fenucure Medical ApS.
Fenucure Medical ApS has published its annual report for 2024. Gross profit came to DKK -873,428, and the net result was DKK -1,529,007.
As of May 28, 2025, Mogens Viktor Madsen has joined the board of directors of Fenucure Medical ApS.
As of May 28, 2025, Preben Andersen has left the board of directors of Fenucure Medical ApS.
As of December 20, 2024, V-BIOTEK HOLDING ApS is registered as an owner of Fenucure Medical ApS with an ownership share of 5%.
As of December 20, 2024, Redwood Foundation ApS is registered as an owner of Fenucure Medical ApS with an ownership share of 5%.
Fenucure Medical ApS has published its annual report for 2023. Gross profit came to DKK -911,893, and the net result was DKK -2,107,951.
Fenucure Medical ApS has published its annual report for 2022. Gross profit came to DKK -1,590,483, and the net result was DKK -3,548,690.
As of May 24, 2022, Alex Gundersen Assens ApS is registered as an owner of Fenucure Medical ApS with an ownership share of 66%.
Fenucure Medical ApS has published its annual report for 2021. Gross profit came to DKK -1,714,364, and the net result was DKK -4,542,747.
Fenucure Medical ApS has published its annual report for 2020. Gross profit came to DKK -2,428,815, and the net result was DKK -3,181,263.
As of September 14, 2020, Niels Christian Beck Vase has joined the board of directors of Fenucure Medical ApS.
Fenucure Medical ApS has published its interim report for the period July 1, 2018 – December 31, 2019.
As of May 8, 2019, Jørgen Schönherr has joined the board of directors of Fenucure Medical ApS.
As of May 8, 2019, Jens Steen Olsen has left the board of directors of Fenucure Medical ApS.
On May 8, 2019, the company changed its name from V-BIOTEK ApS to Fenucure Medical ApS.
As of March 1, 2019, Christian Hother Sørensen is registered as adm. dir. of Fenucure Medical ApS.
As of February 28, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Fenucure Medical ApS.
As of February 28, 2019, VKST REVISION, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Fenucure Medical ApS.
As of February 28, 2019, Jens Steen Olsen has joined the board of directors of Fenucure Medical ApS.
As of February 28, 2019, Preben Andersen has joined the board of directors of Fenucure Medical ApS.
As of February 28, 2019, Alex Gundersen has joined the board of directors of Fenucure Medical ApS.
As of February 28, 2019, Nicolai Fink Gundersen has joined the board of directors of Fenucure Medical ApS.
As of February 28, 2019, Jens Steen Olsen has stepped down as adm. dir. of Fenucure Medical ApS.
Fenucure Medical ApS has published its annual report for 2018. Gross profit came to DKK -608,212, and the net result was DKK -87,579.
As of November 15, 2018, Philip Xavier Severin Møller has stepped down as director of Fenucure Medical ApS.
Fenucure Medical ApS has published its annual report for 2017. Gross profit came to DKK -1,603,315, and the net result was DKK -2,164,303.
Fenucure Medical ApS has published its annual report for 2016. Revenue came to DKK 200,000, and the net result was DKK -1,818,594.
Fenucure Medical ApS has published its annual report for 2015. Revenue came to DKK 1,200,000, and the net result was DKK -1,148,210.
As of February 3, 2015, VKST REVISION, GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Fenucure Medical ApS.
As of February 3, 2015, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Fenucure Medical ApS.
Fenucure Medical ApS has published its annual report for 2014. Gross profit came to DKK -10,000, and the net result was DKK -25,582.
As of October 13, 2014, Philip Xavier Severin Møller is registered as director of Fenucure Medical ApS.
Fenucure Medical ApS has published its annual report for 2013. Gross profit came to DKK -12,500, and the net result was DKK -152,481.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Fenucure Medical ApS.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of Fenucure Medical ApS.
As of April 21, 2008, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of Fenucure Medical ApS.
As of April 21, 2008, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has stepped down as auditor of Fenucure Medical ApS.
As of April 21, 2008, Jens Steen Olsen is registered as adm. dir. of Fenucure Medical ApS.
As of April 21, 2008, Holger Lunden has stepped down as director of Fenucure Medical ApS.
On April 21, 2008, the company changed its name from VIND INVEST ApS to V-BIOTEK ApS.
As of June 7, 2007, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of Fenucure Medical ApS.
As of June 7, 2007, Landboforeningen Nordjylland has stepped down as auditor of Fenucure Medical ApS.
As of February 14, 2005, Landboforeningen Nordjylland has been appointed auditor of Fenucure Medical ApS.
As of February 14, 2005, Holger Lunden is registered as director of Fenucure Medical ApS.
Fenucure Medical ApS was founded on February 14, 2005.
Companies in the same industry and area
CVR 57821159
CVR 40378030
CVR 32780571
CVR 43729810
CVR 46284771
